RxSight, Inc.: Wells Fargo cuts target price to $6 from $9
RXST•Wells Fargo cut its target price for RxSight, Inc. to $6 from $9.
Related News
AtriCure, Inc. target price raised to $70 from $65
ATRC•
VICI Properties Inc: Mizuho cuts target price to $26 from $27
VICI•
Stifel raises Revvity target price to $177 from $110
RVTY•
BRC Inc: Telsey Advisory Group cuts target price to $13 from $25
BRCC•
Novo loses share in Brazil to cheaper generics, but holds up in Canada and India
NVO•